Donate
    Join Us

    Latest News

    Heading 1

    with a request body that specifies how to map the columns of your import file to the associated CRM properties in HubSpot.... In the request JSON, define the import file details, including mapping the spreadsheet's columns to HubSpot data. Your request JSON should include the following fields:... entry for each column.

    Heading 1

    with a request body that specifies how to map the columns of your import file to the associated CRM properties in HubSpot.... In the request JSON, define the import file details, including mapping the spreadsheet's columns to HubSpot data. Your request JSON should include the following fields:... entry for each column.

    Filter
    Select Category
    Research
    News
    Stories of Hope
    Family Conference
    Parents
    Clinical Trials
    Global PWS Registry
    Schaaf-Yang Syndrome
    Advocacy
    Research Blog
    Behavior
    Resource Development
    Clinical Trials Opportunities
    Sleep
    Children 0-3
    Learning
    hopefull
    Children 3-6
    Hunger Satiety
    Mental Health
    Therapeutic Development
    Clinical Issues
    Treatments
    Children 12-18
    Genetic Therapy
    Scoliosis
    ages: 4-7
    Children 6-12
    Endocrinology/Growth Hormone
    Executive Function
    Genetics and Imprinting
    Hyperphagia
    Obesity and Energy Balance
    PWS Research
    Partners
    Trial Results
    Video Gallery
    Volunteer
    cognition
    Picture of FPWR

    FPWR
    FDA Accepts DCCR Filing and Grants Priority Review
    Soleno Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has accepted their New Drug Application (NDA) and granted priority review for DCCR (Diazoxide Choline Controlled-Release), a treatment for patients with Prader-Willi syndrome. The FDA's target action date
    the-comer-family-is-eager-to-meet-you-in-denver-this-october
    The Matesevac Family Welcomes You to Atlanta this September!
    A special contribution by guest blogger Lisa Matesevac. Welcome to the ATL! We are thrilled that our city will host the annual Foundation for Prader-Willi Research Symposium and Family Conference in September 2024! Together with my family and the Georgia
    FDA Grants Rare Pediatric Disease Designation to CSTI-500
    The FDA has granted Rare Pediatric Disease Designation (RPDD) to ConSynance Therapeutics' new investigational drug, CSTI-500 for the treatment of Prader-Willi Syndrome in children and adolescents. This special status is granted to drugs and biologics intended to treat rare diseases,
    Announcing the FPWR Olympics!
    Just like the elite athletes competing in the Olympic Games, our community is passionate, dedicated, and persistent in their pursuit of victory! As our Olympians aim for gold, we are relentlessly working towards treatments for Prader-Willi and Schaaf-Yang syndromes. We
    Soleno Therapeutics Submits New Drug Application for DCCR
    We are excited to share the news that Soleno Therapeutics has submitted its New Drug Application (NDA) for DCCR to the FDA. This application is seeking approval for DCCR to treat hyperphagia in people with PWS ages 4 and older.
    Previous 8 9 10 11 12

    Subscribe to hope.

    If you're looking for the latest information on Prader-Willi syndrome, you’ve come to the right place. FPWR Updates is your source for up-to-date information.

    Subscribe to FPWR News Updates

    Heading 1

    with a request body that specifies how to map the columns of your import file to the associated CRM properties in HubSpot.... In the request JSON, define the import file details, including mapping the spreadsheet's columns to HubSpot data. Your request JSON should include the following fields:... entry for each column.

    Evan and Dr. Fallah